Open Access Highly Accessed Email this article to a friend

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

Anke Reinacher-Schick*, Karsten Schulmann, Dominik P Modest, Nina Bruns, Ulrich Graeven, Malgorzata Jaworska, Richard Greil, Rainer Porschen, Dirk Arnold, Wolff Schmiegel and Andrea Tannapfel

BMC Cancer 2012, 12:349  doi:10.1186/1471-2407-12-349

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?